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Abstract - The article discusses a modification of 
Bergman's minimal mathematical model of the "insulin-
glucose" system, which allows simulating controlled 
exogenous sources of glucose and insulin into the patient's 
blood on the model and investigating the dynamics of 
changes in their concentrations in normal conditions, in 
type I DM and type II DM. A modeling scheme is presented 
in graphic notations of the MatLab / Simulink computer 
mathematics system and a number of computational 
experiments on it are described to determine the type of 
glycemic profiles of glucose and insulin concentration in the 
patient's blood in the noted situations. The fundamental 
possibility of using model mappings in the 
MatLab/Simulink environment for the study and tuning of 
the loop for automatic regulation of the "insulin-glucose" 
balance in the patient's blood using a controlled insulin 
pump is demonstrated. It was also found that the modified 
minimal model can be customized for a specific patient with 
diabetes, which makes it possible to use it to solve the 
problems of individual prediction of the development of a 
diabetic disease in a specific patient. In addition, the 
described model makes it possible to recreate and virtually 
investigate various conditions and cases on it that affect the 
dynamics of insulin and glucose concentrations in the 
patient's blood, for example, when he performs physically 
stressed activities, in the presence of the effects of “aging” of 
insulin-producing cells in the pancreas. iron, etc.  
Keywords - Diabetes mellitus, Insulin-glucose balance, 
Glycemic monitoring, Computer simulation, Model 
personalization, Computational experiment. 
I. INTRODUCTION 
According to the World Health Organization (WHO), 
diabetes mellitus (DM) is currently a global problem on a 
planetary scale. The number of patients with diabetes in 
the world over the past 10 years has more than doubled, 
and is currently approaching 500 million people [1]. It is 
known [2] that DM is dangerous, first of all, due to its 
complications, in particular, such as: blindness, renal 
failure, heart attack, stroke, amputation of the lower 
extremities, etc. are still practically inevitable even if all 
recommendations of the attending physicians are 
followed [3]. Until now, there is not a single effective 
method of treatment to get rid of DM. It is for these 
reasons that such tasks are important as: increasing the 
effectiveness of diabetes prevention, ensuring high-
quality current monitoring of the condition of a patient 
with diabetes, performing operational prediction and 
managing the concentration of glucose and insulin in his 
blood. In this case, the formation of insulin therapy 
regimens for patients with DM is based on the experience 
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and intuition of a doctor and is more an art [4], a   
medico-creative process, rather than the result of 
deductive inferences based on objective formalized 
diagnostic characteristics of a diabetic disease and 
information about the individual characteristics of its 
course in specific patients. Note that in the empirical 
selection of the parameters of insulin therapy for diabetes, 
the doctor, fearing the occurrence of a hypoglycemic 
state in the patient, is often limited only by the weakening 
of hyperglycemia. At the same time, the patient's 
condition remains insufficiently compensated, which 
condemns him to subsequent late vascular complications. 
Here, one of the most effective ways to increase the 
doctor's confidence in the safety of the process of 
normalizing glycemia in a patient with diabetes and, 
accordingly, to prevent or at least significantly reduce the 
likelihood of developing complications from diabetes is 
to use computational research sites at the stage of 
determining the modes and parameters of insulin therapy, 
where the objects of study are individualized (i.e. 
customized for specific patients with diabetes) 
mathematical models of the dynamics of glucose and 
insulin in their blood. 
The aim of this work is to construct and analyze the 
options for using a patient-oriented simulation 
computerized model for regulating the concentration of 
glucose and insulin in the blood of a patient with diabetes 
with the possibility of studying different types of this 
disease on it. 
Note that in relation to the subject of this article, 
models and methods of conducting computer experiments 
with them are of interest, which describe the processes of 
ensuring the balance of "insulin-glucose" in the blood of 
a patient with diabetes. The need for just such models and 
the results of their research is due to the fact that in the 
treatment of DM, the primary and main task is to 
normalize blood glucose levels and prevent hypo- and 
hyper-glycemic conditions in a patient. Naturally, the 
presence of a correct formal description of the "insulin-
glucose" balance in the blood, adapted and adjusted for a 
particular patient, makes it possible to solve a number of 
clinical problems aimed at improving the health of a 
patient with diabetes. This is, firstly, the organization of 
continuous monitoring of the glucose level before and 
after its correction (if necessary); secondly, the modeling 
of the development of controlled endocrine and 
physiological processes using various schemes for 
correcting the insulin-glucose balance. In this case, the 
correction of the glucose concentration in the patient's 
blood can be manual in nature (then the task of the model 
system is to predict the conditions of potentially 
unfavorable development of processes and to warn the 
patient about the need for correction), or it can be carried 
out semi- or completely automatically (by using devices 
for minimally invasive exogenous insulin delivery with a 
guided insulin pump). In addition, the process of external 
insulin delivery (bolus, basal, or combined) and the 
patient's body response to such an effect should also be 
investigated under model conditions, at least for the 
correct calculation of the parameters of external insulin 
exposure. 
II. LITERATURE REVIEW 
From a mathematical point of view, biological 
functional systems, which include systems for regulating 
blood glucose concentration, are stochastic nonlinear 
systems with multi-compartment interactions [5]. Such 
systems include many interacting components at the 
organ, tissue, cellular and subcellular levels, reflecting 
the dynamic processes of controlling changes in the 
concentration of glucose and insulin in the blood plasma. 
simplifiedly called the "insulin-glucose" system. 
When creating mathematical model constructions and 
schemes that allow performing computational 
experiments in order to predict the dynamics of changes 
in glucose and insulin concentrations in the blood of a 
patient with diabetes and to solve problems of their 
control, the following approaches are used [6, 7]: 
1). Empirical or “black box” models that use real 
physiological and other data about the patient's 
condition that can, to varying degrees, affect the 
controlled levels of glucose and insulin in the blood 
of a patient with diabetes - these are the previous 
values of glucose and insulin concentrations, 
physiological parameters organism (weight, 
temperature, blood pressure, cardiac parameters, 
blood composition, etc.), properties of exogenous 
sources of glucose and insulin intake, etc. As basic 
mathematical representations, analytical schemes 
based on linear autoregressive mappings are used [8, 
9, 10] and neural network mathematical constructions 
[11,12]. 
2). Theoretical or "complete" models, based primarily on 
the laws of physiology, built without involving 
additional empirical assumptions, - they describe 
physiological and pathophysiological processes 
occurring at the organ, tissue, cellular and subcellular 
levels, including the distribution and dynamic 
changes in glucose concentration and insulin in 
various organs and tissues of the body, the processes 
of absorption of exogenous glucose, its utilization and 
elimination, natural (in the pancreas) and artificial 
(from exogenous sources) mechanisms of insulin 
production, etc. Formal descriptions of complete 
models are based on compartment mappings and the 
mathematical apparatus of ordinary differential 
equations (ODE) [13, 14, 15], including ODE with 
delay [16, 17], as well as the apparatus of integro-
differential formal notations [18] and graph theory 
[19]. 
3). Mixed or semi-empirical models using somewhat 
simplified mathematical constructions of theoretical 
models of key physiological and pathophysiological 
processes occurring at the organ and tissue levels and 
determining the conditions and mechanisms of 
regulation of carbohydrate metabolism in the patient's 
body, supplemented by empirical formed parameters, 
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characteristics and functions. The empirical 
components introduced into the formal model 
schemes make it possible to reproduce in simulation 
conditions the functions of exogenous intake of 
glucose and insulin into the patient's body [20, 21], 
including variants with the function of controlling the 
concentration of glucose in the blood [22, 23], the 
mechanisms of the relationship between blood 
glucose and subcutaneous adipose tissue [24], 
characteristics reflecting changes in glucose 
concentration in the interstitial space [25], factors that 
take into account the effect of physical activity on the 
functioning of the insulin-glucose system [26], etc. 
Analyzing the mentioned model concepts, it should 
be noted that not all the noted formal structures are 
applicable for individual adaptation for specific patients, 
for organizing guided insulin therapy, and also for setting 
model notations for patients with different types of 
diabetes. 
Thus, empirical models based on autoregressive 
structures make it possible to effectively solve the 
problem of predicting changes in the level of glucose in a 
patient's blood, since according to the analysis of time 
series of real measurements of its concentration, it is 
possible to generate a forecast of their future values based 
on known data from the past. It should be noted here that 
such models make it possible to predict with a 
sufficiently high reliability the concentration of glucose 
in the blood only for the near future - from 30-45 minutes 
[8.9] to 4 hours [10]. These models have proven 
themselves well when customizing them for specific 
patients with type 1 diabetes and without diabetes, but 
they are not very effective in recreating type 2 diabetes. 
Also, autoregressive formal schemes are not sufficiently 
adapted to the reproduction of exogenous sources of 
glucose and insulin intake, to the implementation of 
blood glucose control regimes, to taking into account 
other physiological factors in the regulation of 
carbohydrate metabolism in the blood. 
Neural network empirical models are also generally 
quite efficiently tuned to specific patients and make it 
possible to predict future glucose levels [11,12] in his 
blood based on several previous values and / or some 
currently existing factors regulating carbohydrate 
metabolism. At the same time, it should be borne in mind 
that neural network models, before using them, require a 
training procedure, i.e. in fact, individualized adaptation-
adjustment of the model for a specific patient, and this 
procedure is rather complicated and time-consuming, 
which significantly hinders its widespread use both in 
solving research problems and in the medical practice of 
an endocrinologist. Also, neural network model 
structures are rather difficult to adapt to the tasks of 
automating insulin therapy in patients with diabetes. 
Theoretical model representations use equations 
characterizing physiological and pathophysiological 
processes associated with the insulin-glucose system, 
written, if possible, on the basis of "first principles" 
("First principles" are natural laws of nature that allow to 
substantiate any phenomenon without additional 
empirical assumptions or special models). This approach 
leads to the need to use in formal schemes high-order 
systems of ordinary (often nonlinear) differential, 
integro-differential, differential-graph equations. As 
examples of such models, let us mention J.T. Sorensen 
[27] (edited by researchers Parker R.S., Doyle F.J. et al. 
[28,29]), C. Cobelli et al. [30,31], Archimedes [32,33]. 
These models contain from 7 to 30 differential equations 
describing the mechanisms of glucose production and 
absorption, insulin release and utilization, and other 
physiological and pathophysiological processes that 
affect the “insulin-glucose” balance in the patient's blood. 
All noted models allow their customization for specific 
patients with diabetes, provide the opportunity to conduct 
model studies of all known types of diabetes (primarily 
types 1 and 2), make it possible to effectively predict the 
dynamics of changes in the concentration of glucose in 
the blood of a patient with diabetes in various life 
situations , and also on these models it is possible to 
recreate exogenous sources of glucose and insulin, incl. 
working in an automatic mode of insulin therapy for a 
patient with diabetes. However, the high and often 
excessive complexity of the development of such models, 
the significant difficulties in collecting and determining 
the values of biological variables that must be taken into 
account in their formal notations, prevent the widespread 
introduction of these model concepts into the clinical 
practice of endocrinologists. 
In this regard, semiempirical models of the insulin-
glucose system are the most convenient for 
implementation in medical practice for treating patients 
with diabetes. As a rule, mixed models are a system of 2-
3, less often 4-6 nonlinear differential and / or integro-
differential equations of the first order, on the right side 
of which there are a number of components reflecting the 
mechanisms of production, exogenous intake, utilization, 
elimination of glucose and insulin, as well as, if 
necessary, recreating the influence of other physiological 
parameters of the body associated with carbohydrate 
metabolism. Among the semiempirical models of the 
insulin-glucose system, we note the following: 
1) The minimal model (Bergman R.N. [14], which has 
three ODEs (equations for the dynamics of glucose, 
insulin and an auxiliary variable describing the 
dependence of the concentration of insulin in the 
blood on the amount of absorbed glucose). 
2) Model Sturis J. [13], which includes six TACs and is 
based on two negative feedbacks describing the 
absorption of glucose by insulin and the release of 
insulin by the pancreas depending on the amount of 
glucose supplied. 
3) Three-piece model Nikita K.S. [34], in the 
composition of three TACs - two TACs for the 
dynamics of insulin absorption (ultrashort and short-
acting) and one TAC of changes in the concentration 
of glucose in the patient's blood caused by the last 
meal. 
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4) Bennett D.L. and Gourley S.A. [13,16], in which 
systems of two ODEs with a lagging argument are 
used to describe the dynamics of glucose and insulin. 
These models subsequently underwent many 
modifications and refinements, which made them more 
universal and flexible to the real conditions of insulin 
therapy for patients with diabetes. These are the already 
mentioned models with exogenous sources of glucose 
and insulin [20,21], with components of semi-automatic 
control of patient's insulin therapy [22,23], which made it 
possible to significantly increase the level of adequacy of 
empirical models (especially Bergman R.N. medtli) 
under conditions of type 1 diabetes ... These are models 
that take into account the mechanisms of the relationship 
between the blood glucose content and subcutaneous 
adipose tissue [24], reflecting factors influencing the 
change in the glucose concentration in the interstitial 
space [25], etc. 
Analysis of the mathematical structures of the 
mentioned mixed models showed that almost all of them 
can be used for the tasks of predicting changes in the 
concentration of glucose in the blood at different stages 
of the breakdown of diabetes disease in a patient, as well 
as with exogenous regular or irregular intake of glucose 
into the patient intravenous intake of insulin into the body 
of a patient with diabetes, incl. when using an insulin 
pump controlled by feedback from blood glucose sensors. 
However, among the semiempirical model 
representations of the carbohydrate balance system in the 
patient's blood, the Bergman R.N. [14] and its 
modifications are, perhaps, the most convenient for 
reconstruction by means of computer mathematics due to 
the moderate complexity of the mathematical 
representation of this model, the high flexibility of its 
analytical design, and the good adaptability of the formal 
scheme of the model to the implementation of control 
actions. 
III. MATERIALS AND METHODS 
As software tools necessary for the development and 
construction of a model range for carrying out 
computational experiments with models of the insulin-
glucose system, computer mathematics software systems, 
such as MapleModeller or SciLabXCos, can be used. 
However, the Matlab software system of computer 
mathematics (Matrix Laboratory) [35] with the Simulink 
extension possesses the best tools for simulation 
computational modeling. This environment is equipped 
with a good high-level language and an interactive 
environment for graphical visual programming, 
numerical calculations and visualization of the results of 
computational experiments with multi-domain dynamic 
systems and processes. 
It is known [36] that an increased blood glucose level 
can be initiated by the following reasons: 
a) insufficient production of insulin by β-cells of the 
pancreas; 
b) the molecular structure of insulin is changed 
("defective" insulin); 
c) insulin is not recognized by cell receptors. 
In case of insufficient insulin production (case (a)) 
diabetes mellitus is called insulin-dependent, or type I 
diabetes, in cases (b) and (c), when enough insulin is 
produced, but it is not recognized or is "defective", 
diabetes is called non-insulin dependent, or type II 
diabetes. 
Let us introduce a number of starting points: 
1) There is a certain patient-specific "nominal (normal, 
acceptable) level" of glucose concentration in the 
blood G0 . 
2) If the current glucose concentration exceeds the value 
G0 , i.e. when ( )G t G> 0 , insulin is produced in 
proportion to the difference ( )( )G t G− 0  (often with 
some time delay). 
3) Insulin is a conductor of glucose through the cell 
membrane, thus mutual utilization (elimination) of 
insulin and glucose occurs in proportion to the 
product of their concentrations in the blood. 
4) When the level of glucose concentration in the blood 
falls below the level G0 , i.e. when ( )G t G< 0 , there is 
a release of glucose from the liver in proportion to the 
difference ( )( )G G t−0 . 
5) After exceeding the current concentration of glucose 
in the blood of a certain upper value Gcr , i.e. when 
( )G t G> cr , glucose is excreted from the body through 
the kidneys. 
6) Insulin circulating in the blood can be in two forms - 
in a free state and associated with proteins. 
Hereinafter, insulin will always be understood as free 
insulin. 
Based on the above and modernized equations of the 
Bergman minimal model. system "glucose-insulin", given 
in [21, 37], we will form the following system of 
nonlinear differential equations characterizing the 
dynamics of changes in glucose and insulin in the blood 
of a patient with diabetes:  
( ) ( ) ( ) ( ) ( ) ( )
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )
,
dI t
G G G t I t L t
dt
dG t
G G G t I t G G S t
dt
α θ η




 = − − +
0 0
0 0 cr cr
− −
+ + − −
(1) 
where ( ) , ,G t G G0 cr  – the previously mentioned 
designations; ( ) ,G G t G= −0 0− ( ) ,G G G t= −+0 0  ( ) ;G G t G= −cr cr−  
( )I t  – the concentration of insulin in the blood at a point 
in time t ; α  – coefficient of insulin production by β-cells 
of the pancreas at ( )G t G> 0 ; η  – coefficient of utilization 
of insulin by glucose; γ  – coefficient of glucose 
withdrawal from the liver to maintain its normal level in 
the blood; ν  – coefficient of glucose utilization by 
insulin; µ  – parameter of elimination of glucose through 
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the kidneys at ( )G t G> cr ; (note that the values 
µνληα ,,,,  are personalized values); ( )L t  – a function 
that takes into account the external supply of insulin; 
( )S t  – a function that takes into account the flow of 
glucose into the patient's blood (for example, as a result 
of his nutrition); ( )xθ  – Heaviside function of the form: 
( )
0,  if  x 0
,




              (2) 
where one of the following values is used as an 
argument: , ,x G G G ∈  
+
0 0 cr
− − . 
Using the graphic notations of the MatLab / Simulink 
environment, we will form the following model 
constructions of the equations of system (1) - a model of 
the dynamics of insulin changes (Fig. 1) and a model of 










































Fig. 2. Model of the dynamics of changes in glucose. 
In these structures: block «  1 .s » – integrator; blocks 
«I0» and «G0» – setters of the initial conditions of the 
integrator; block « » –  multiplier by the corresponding 
coefficient α, η, γ, ν or μ; subblocks « -0G », «L(t)», 
«G(t)∙I(t)», « +0G », « -crG », «S(t)» are intended to form the 
corresponding elements of the first equation system (1). 
To determine the regularities recreated in the «S(t)» 
and «L(t)» subunits, simulating external sources of 
glucose and insulin intake, let us set out mathematical 
descriptions of the processes of glucose and insulin 
intake. 
Thus, a single act of glucose intake into the patient's 
body from an exogenous source is modeled by a non-
negative and one-extreme Gaussian function [37]: 












,             (3) 
where ( )0AS  – the amplitude, which determines the 
maximum value of the peak of the injection of glucose 
into the blood after a meal; ( )T 0  – the interval defining 
the moment of the beginning of feeding (the beginning of 
exogenous glucose intake) relative to the beginning of the 
model experiment (this moment corresponds to 0=t ); σ  
– variance, which controls the width of the peak, i.e. in 
fact, the rate of assimilation of food by the patient, the 
full dose of which is ( )0A σ 2S  [21], while it is obvious that 
95% of the food (respectively, 95% of exogenous 
glucose) will be assimilated by the body in an interval 
equal to σ2 . The value of the variable corresponding to 
the maximum of the function ( )( )0S t  is determined by the 
formula: 
( )
( )( ) ( )




       (4) 
It is believed [21] that the food taken by the patient is 
completely converted into glucose on average within two 
hours after the beginning of the feeding process, i.e. the 
moment ( )t 0max  is 1 hour from the start of the meal ( )( )t T− 0 . 
Three meals a day (three daily exogenous intake of 
glucose into the patient's body), provided that the daily 
meal is equivalent to two morning or evening meals, can 
be described as follows [37]: 
( ) ( ) ( )( ) ( )( ) ( )( )( )0 2 ,S t A T T Tψ ψ ψ= + +1 2 3c S           (5) 











2 at the same 
time, as a first approximation, we can assume that the 
rate of assimilation of food by the patient is the same in 
all periods of food intake. 
To set a formal description of the subblock «L(t)», 
which simulates an exogenous source of insulin intake, 
let us take into account that the need to forcibly inject 
insulin into the patient's blood arises when the patient has 
diabetes mellitus and has certain difficulties with blood. 
There are two ways of getting insulin into a patient's 
blood from an external source. 
The first method involves the introduction of insulin 
into the blood in a volume proportional to the value of the 
difference ( )( )G t G− 0 , moreover, only after revealing the 
fact of such an excess. Mathematically, this method is 
described by the following relationship: 
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( )( )
,  if 0
,
0,  if 0
k G t G G t G
L t
G t G






            (6) 
where kI  – is the coefficient of the relationship between 
glucose and insulin concentrations. 
The second method is based on a relay mechanism for 
controlling the process of insulin intake into the patient's 
body, which is triggered when the moment the condition 
is met ( )G t G G− > *0 , where G*  – is some permissible 
excess of the minimum glucose concentration G0 . From 
this moment, insulin is supplied into the patient's blood at 
a constant concentration G0 . Mathematically, this method 




,  if 
.
0,  if  
L G t G G
L t
G t G G






                         (7) 
In both schemes of organizing the supply of 
exogenous insulin into the blood of a patient with 
diabetes, the supply is stopped as soon as the condition 
for the start of its administration is stopped. 
IV. RESULTS 
Here are some of the results of computational 
experiments on the simulation test site of the "insulin-
glucose" system, assembled on the basis of the structural 
structures shown in Fig. 1 and Fig. 2. The purpose of the 
experiments is to determine the establishment of daily 
glycemic profiles of glucose and insulin in the patient's 
blood in the situations: 
Situation 1. The patient is healthy. The function of 
insulin production by the β-cells of the pancreas is 
normal. Excess blood glucose is promptly neutralized by 
insulin produced by the body in the right amount. 
Situation 2. The patient has type I diabetes mellitus. 
There is an insufficient level of insulin production by β-
cells of the pancreas. Correction of the glucose-insulin 
balance in the patient's blood is not performed. 
Situation 3. The patient has type II diabetes 
mellitus. The pancreas makes the required amount of 
insulin, but this insulin is “defective”. Correction of the 
"glucose-insulin" balance in the patient's blood is not 
fully carried out. 
Situation 4. The patient has type I diabetes mellitus 
and there is a controlled system for introducing 
exogenous insulin into his blood. There is an 
insufficient level of insulin production by the pancreas or 
insulin is not produced in it at all. There are means for 
continuous monitoring of blood glucose concentration 
and a system for automatic correction of it by forcibly 
injecting insulin into the blood from an exogenous source. 
Now let us set the initial parameters necessary for 
organizing correct modeling (partially taking into account 
the data given in [21, 37]): 
1) Periods of simulation: 1 day (24 hours). 
2) The number of patient meals (glucose intake from an 
exogenous source) per day is 3 with the following 
time stamps: 08-00, 14-30, 19-30 hours. 
3) Daily markers of the patient's blood glucose maxima: 
09-00, 15-30, 20-30 hours. 
4) Concentrations of glucose in the patient's blood: 
– before meals (on an empty stomach): 3,3 ... 6,1 
mMol/l; 
– after each meal (after 1 hour): 8,9 mMol/l; 
– minimum allowable: 3,3 mMol/l; 
– nominal (normal): 5 mMol/l; 
– critical: 10 mMol/l. 
5) The insulin concentration in the patient's blood varies 
from 0 to 170 mU/ml (mU – milli units of insulin). 
6) Typical values of the coefficients in the equations of 
system (1), independent of the situations under 
consideration: 
– coefficient of utilization of insulin by glucose; 
– coefficient of glucose output from the liver; 
– coefficient of glucose excretion through the 
kidneys. 
7) Coefficient of insulin production by β-cells of the 
pancreas: situations 1 and 3 – 15=α ; situations 2 and 
4 -– 3=α . 
8) Coefficient of glucose utilization by insulin: situations 
1, 2 and 4 – 6=ν ; situation 3 – 1ν = . 
Here are some results from computational 
experiments. 
Situation 1. The patient is healthy. The blood glucose-
insulin balance is normal. The glycemic profiles of 
glucose and insulin concentrations have the form shown 
in Fig. 3, and their daily dynamics corresponds to the 
clinical data of a healthy organism.  
 
Fig. 3. Daily glycemic profiles of glucose (a) and insulin (b) 
concentrations in the blood of a healthy patient. 
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The blood glucose level does not exceed the critical value 
of 10 mMol/l. In the first approximation, the selected 
values of the coefficients in model (1) can be considered 
correct. Then, by manipulating the values of these 
coefficients, one can expect physiologically correct 
results from the model for certain disorders of 
carbohydrate metabolism. However, this does not replace 
the mandatory identification and adjustment procedures 
for the model for specific patients when using it in 
clinical practice. 
Situation 2. A patient has type I diabetes mellitus. 
The insulin produced by the patient's body is not 
sufficient to eliminate glucose. In this case, the glycemic 
profiles of glucose and insulin concentrations in the 
blood take the following form - see Fig. 4. Insufficient 
insulin level leads to the fact 
 
Fig. 4. Daily glycemic profiles of glucose (a) and insulin (b) 
concentrations in the blood of a patient with type I diabetes. 
that after each meal there is a rapid increase in the 
concentration of glucose in the patient's blood, exceeding 
the critical level of 10 mMol/l. Then the glucose 
concentration slowly decreases, but does not reach the 
normal value 5 mMol/l and remains at a sufficiently high 
level. This effect naturally leads to the fact that excess 
glucose from the body's blood is excreted through the 
kidneys. This situation is characterized by blood effects 
typical of type I diabetes. 
Situation 3. The patient has type II diabetes 
mellitus. The pancreas of the patient's body produces 
insulin in sufficient quantities, but it does not have the 
necessary properties for efficient utilization of glucose, 
i.e. is “defective”. The glycemic profiles of glucose levels 
and moderately “defective” insulin in the blood are as 
follows - see fig. 5. It can be seen that, as in the case of 
diabetes mellitus I, after each meal there is a rapid 
increase in the concentration of glucose in the blood of a 
patient with diabetes mellitus II; however, insulin 
utilization requires 20-30% more insulin than in a healthy 
person. organism (Fig. 3). In addition, there is a slowed 
down, compared with the norm, process of lowering the 
blood glucose level and reaching its normal value only by 
the end of the patient's daily activity period (by 00 hours). 
 
Fig. 5. Daily glycemic profiles of glucose (a) and insulin (b) 
concentrations in the blood of a patient with type II diabetes (a case 
with moderately "defective" insulin). 
Situation 4. A patient has type I diabetes mellitus and 
there is a controlled system for introducing exogenous 
insulin into his blood. There are means of continuous 
monitoring of the patient's blood glucose level and a 
controlled system for continuous delivery of insulin into 
the blood from an exogenous source, which is equipped 
with an insulin pump [38]. Let the proportional pump 
control mode be selected in accordance with expression 
(6). The coefficient of the relationship between the 
concentrations of glucose and insulin is assumed to be 
equal 22k =I , since it is generally accepted [21] that 1 
Unit of insulin capable of utilizing 22 mMol glucose. 
Then the glycemic profiles of glucose and insulin 
concentration in the patient's blood take the form shown 
in Fig. 6. Here it is necessary to pay attention to the fact 
that in a patient with type I diabetes mellitus, in the 
absence of an automatic system for correcting the 
glucose-insulin balance in the blood by exogenous 
insulin, the maximum permissible glucose concentration 
level of 10 mMol/l is exceeded after each meal by the 
patient (see Fig. 4.a).  
 
Fig. 6. Daily glycemic profiles of the concentration of glucose (a) 
and insulin (b) in the blood of a patient with type I diabetes 
mellitus, provided with a continuous supply of exogenous insulin 
with a proportional regulator of its consumption. 
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When such a patient enters the bloodstream of insulin 
from a controlled external source, the concentration of 
glucose in his blood exceeds the maximum allowable 
value of 10 mMol/l only once - about 15-30 in the 
afternoon for a relatively short time after the day 
(maximum) food intake by the patient, which gives the 
maximum injection exogenous glucose into the body 
(Fig. 6.a). 
V. DISCUSSION 
So, the considered mathematical model of the 
"insulin-glucose" balance (system of equations (1)), 
despite the undefined "roughness" of the formal 
description and its model representations using MatLab / 
Simulink, as well as the results of computational 
experiments carried out on this model, demonstrate the 
following dynamics changes in the model concentrations 
of glucose and insulin in the patient's blood, which fully 
corresponds to the real glycemic profiles of the 
concentrations of glucose and insulin in the blood of the 
human body, both for its healthy state and in the presence 
of type I and II diabetes mellitus. Thus, the model 
dynamic sections of the diurnal processes of changes in 
the level of glucose and insulin in the blood of a healthy 
patient presented in Fig. 3 adequately converge with the 
dynamical processes of the same name obtained in real 
examinations of practically healthy people (see, for 
example, [39]). Model glycemic profiles of glucose and 
insulin concentration in the blood of a patient with type I 
diabetes mellitus (Figs. 4 and 6) also identically reflect 
the dynamics of real analogous profiles obtained during 
glycemic control of patients with type I diabetes (see data 
in [39, 40]). The calculated profiles of changes in glucose 
and insulin levels obtained for a patient with type II 
diabetes (Fig. 5) also provide good agreement with the 
real results of daily glycemic monitoring in patients with 
type II diabetes (see, for example, [41]). 
It should be noted that the described model of the 
"glucose-insulin" balance in the patient's blood has good 
potential for its further improvement. 
So, it is of interest to model such behavior of the main 
organ-generator of insulin (pancreas), which reflects its 
dynamic "fatigue", ie. allows to recreate in model 
conditions a variable rate of insulin production with 
limitation of the upper limit of such production. To 
simulate this situation, it is sufficient in the first equation 
of system (1) to make the constant coefficient of insulin 
production variable, depending on the temporal 
characteristic or other changing factors. 
Replacing the coefficients and, which determine the 
processes of mutual utilization of insulin and glucose in 
the corresponding equations of system (1) by functional 
operators that take into account the rate of glucose 
consumption under the influence of physical exertion on 
the patient's body, it is possible to reproduce on the 
considered model of carbohydrate metabolism various 
"insulin-glucose" consequences in the patient's blood 
from his hard work, physical exercise, sports and other 
similar physically stressful activities. 
The model of insulin-glucose balance in the patient's 
blood described in this article can be generally 
recommended for implementation in clinical practice to 
improve the quality of insulin therapy in patients with 
diabetes mellitus, provided that the issues of individual 
identification and adjustment of the mathematical 
description of carbohydrate metabolism for specific 
patients with diabetes mellitus are resolved. The formal 
construction of the model description of the insulin-
glucose system in the patient's blood (equations of system 
(1)) allows it to be adjusted for a specific patient by 
adjusting the values of the coefficients of insulin 
production by the pancreas (α ), mutual utilization of 
insulin and glucose (η ,ν ), and glucose output from the 
liver ( γ ), elimination of glucose through the kidneys ( µ ), 
as well as adjusting the values of the nominal G0  and 
critical Gcr  levels of glucose concentration. This 
significantly increases the flexibility and scope of the 
considered model, makes it "patient-oriented", which is 
especially important in the case of its introduction into 
the clinical practice of an endocrinologist in order to 
study and predict the development of a diabetic disease in 
a particular patient. 
Also, the methods and mechanisms of organizing 
glycemic monitoring of blood glucose levels with the 
automation of the process of exogenous insulin entering 
it using a controlled insulin pump also require some 
improvement. Here it is possible to propose a wider use 
of the existing developments in this area - see, for 
example, [38,42], which describes systemic approaches 
to the organization of glycemic control of the blood state 
of a patient with type I diabetes mellitus and systemic 
issues of building an insulin pump with its control circuit. 
Obviously, the modified Bergman minimal model of 
the "insulin-glucose" system in the patient's blood 
considered in this article makes it possible to recreate and 
study under model conditions various clinical aspects of 
carbohydrate metabolism both for a healthy patient's 
body and in the presence of pathologies, including 
diabetes mellitus I and II types, changes in the balance of 
"insulin-glucose" during physical exertion, the effects of 
"aging" of the insulin-production capacity of β-cells of 
the pancreas. 
VI. CONCLUSION 
The authors have shown the possibility of using 
modern software tools - the MatLab/Simulink computer 
mathematics system, initially focused on solving various 
dynamic problems of scientific, technical, statistical, 
optimization focus using the mechanisms of simulation 
modeling and the theory of experiments, to build 
dynamic simulation models of carbohydrate metabolism 
processes in the blood a patient suffering from diabetes 
mellitus and conducting research on this model. The 
fundamental possibility of using the MatLab/Simulink 
software system for organizing controlled computational 
experiments on a model range of the insulin-glucose 
system, as well as for high-quality visualization of the 
key dynamic characteristics of the studied processes of 
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carbohydrate metabolism in the blood of a patient with 
diabetes mellitus, has been demonstrated. The obtained 
model results showed good agreement with real glycemic 
profiles of insulin and glucose concentrations in the 
blood of a healthy patient and in the presence of diabetes 
mellitus. 
Thus, this article shows how an endocrinologist can 
effectively use the MatLab/Simulink software 
environment as a solid modern clinical research tool 
aimed at studying the dynamics of the development of 
signs of pathological processes associated with 
carbohydrate metabolism in order to ultimately improve 
the quality and efficiency diabetes mellitus treatment. 
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